The weekly litigation news digest is live. Subscribe now

IP Verse

Dulaglutide For The Treatment Of Chronic Kidney Disease - EP3630164

The patent EP3630164 was granted to ELI Lilly on Aug 23, 2023. The application was originally filed on May 24, 2018 under application number EP18730908A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3630164

ELI LILLY
Application Number
EP18730908A
Filing Date
May 24, 2018
Status
Granted And Under Opposition
Jul 21, 2023
Publication Date
Aug 23, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKMay 23, 2024ELKINGTON AND FIFEADMISSIBLE

Patent Citations (3) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2010196405
DESCRIPTIONUS7452966
INTERNATIONAL-SEARCH-REPORTWO2011138421

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents